Sofwave Medical to Participate in the Needham 23rd Annual Healthcare Conference

March 28, 2024 8:00 AM EDT

SAN CLEMENTE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will provide a corporate update and participate in one-on-one investor meetings at the Needham 23rd Annual Healthcare Conference, to be held virtually from April 8-11, 2024.

Needham 23rd Annual Healthcare ConferenceFormat: Corporate update and one-on-one investor meetingsPresentation Date: Tuesday, April 9, 2024Presentation Time: 10:15 a.m. ETWebcast: Click Here

About Sofwave Medical Ltd.Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin), neck tissue and arm, as well as the short-term improvement in the appearance of cellulite and treatment of acne scars, providing physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. 

Contact - [email protected]

Investor Contact:Brian RitchieLifeSci Advisors LLC(212) 915-2578[email protected]

Primary Logo

Source: SofWave Medical, Ltd.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Globe Newswire, Press Releases

Related Entities

Needham & Company, FDA